Cover Image

Diabetic retinopathy: major unmet medical challenge

Joanna M. Tarr, Kirti Kaul, Eva M. Kohner, Rakesh Chibber
  • Kirti Kaul
    Affiliation not present
  • Eva M. Kohner
    Affiliation not present
  • Rakesh Chibber
    Affiliation not present


Since diabetes is now a global epidemic, the incidence of retinopathy, a leading cause of blindness in patients aged 20 to 74 years, is also expected to rise to alarming levels. The risk of development and progression of diabetic retinopathy is closely associated with the type and duration of diabetes, blood glucose, blood pressure and possibly lipids. It is an unmet medical need that can lead to severe and irreversible loss of vision in people of working age worldwide. The aim of this review is to give an overview of the clinical and anatomical changes during the progression of retinopathy, the underlying pathogenic mechanisms that link hyperglycaemia with retinal tissue damage, current treatments and the emerging pharmacological therapies for this sight-threatening complication of diabetes.

Full Text:

Submitted: 2011-06-10 11:28:15
Published: 2011-07-05 11:04:58
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2011 Joanna M. Tarr, Kirti Kaul, Eva M. Kohner, Rakesh Chibber

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185